MediWound Cash Flow - Annual (NASDAQ:MDWD)

Add to My Stocks
$6.48 $0.03 (0.47%) MDWD stock closing price Sep 18, 2018 (Closing)

For analyzing any company like MediWound from an investment perspective, its important to check the cash flow statement. While its important to look at the MediWound debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as MediWound revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement is essetial while conducting the MediWound cash flow analysis and can be used to measure the operating performance of MediWound compared to various industry peers like DRRX stock and SLUXY stock. The cash from operating activities for MediWound is $ 2017, which saw a decrease from previous year.

View details of MediWound cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-------
Net Increase (Decrease) in Assets Liabilities-2.44M1.98M---0.38M-1.94M-
Cash From (used in) Discontinued Operations6.05M---5.18M-1.94M
Other Adjustments Net1.52M-0.13M1.29M1.26M--14.5M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.04M-0.67M-0.37M-0.36M-0.26M-0.06M-0.76M
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments1.16M2.11M36.16M-36.93M-2.5M-4.2M
Other Cash Inflow (Outflow) from Investment Activities-----0.08M-0.34M-6.81M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares22.66M--72.13M16.07M-6.72M
Issuance (Repayment) of Debt Securities----3.01M1.55M-
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities-------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---0.14M-0.45M---
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year28.86M42.5M25.42M7.05M-3.66M2.72M
Cash & Equivalents at Year End36.06M28.86M42.5M25.42M7.05M-3.66M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Durect financial analysis

MediWound stock price history provides insight into historical stock price fluctuations, and MediWound stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • MediWound had a Net Change in Cash and Cash Equivalents of $7.2M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the MediWound stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. MediWound lost $-16.45M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $- for MDWD stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. MediWound earned $22.99M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For MediWound Cash Flow

Annual Cash Flow Statements For Mediwound Ltd Peers

Durect cash flow, NUO THERAPT-OLD cash flow, Recro Pharma cash flow, Uluru cash flow